Update cognition of nonalcoholic fatty liver disease/metabolism-associated fatty liver disease
- PMID: 35620163
- PMCID: PMC9128561
- DOI: 10.1002/cdt3.14
Update cognition of nonalcoholic fatty liver disease/metabolism-associated fatty liver disease
Keywords: metabolism associated fatty liver disease; nonalcoholic fatty liver disease.
Conflict of interest statement
The authors declare no conflict of interest. Professor Yiming Mu is a member of Chronic Diseases and Translational Medicine editorial board and is not involved in the peer review process of this article.
References
-
- Hardy T, Oakley F, Anstee QM, Day CP. Nonalcoholic fatty liver disease: pathogenesis and disease spectrum. Annu Rev Pathol. 2016;11(1):451‐496. - PubMed
-
- Kim GA, Lee HC, Choe J, et al. Association between non‐alcoholic fatty liver disease and cancer incidence rate. J Hepatol. 2017;S0168‐8278(17):32294‐32298. - PubMed
-
- Yki‐Järvinen H. Non‐alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014;2(11):901‐910. - PubMed
-
- Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction‐associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202‐209. - PubMed
-
- Krawczyk M, Liebe R, Lammert F. Toward genetic prediction of nonalcoholic fatty liver disease trajectories: PNPLA3 and beyond. Gastroenterology. 2020;158:1865‐1880. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
